GET THE APP

Journal of Osteoporosis and Physical Activity

Journal of Osteoporosis and Physical Activity
Open Access

ISSN: 2329-9509

+44 1478 350008

Short Communication - (2022)Volume 10, Issue 5

Pathogenesis and Diagnosis of Osteoporosis

Manchala Agarwal*
 
*Correspondence: Manchala Agarwal, Department of Sports and Physical Fitness, University of Hyderabad, Hyderabad, India, Email:

Author info »

Description

Osteoporosis is distinguished by low bone mass and microarchitectural deterioration of bone tissue, prompting improved bone fragility and the ensuing increase in fracture risk. It is a typical condition affecting one of every three women and one out of 12 men, bringing about significant morbidity, excess mortality, and health and social services expenditure. Therefore it is critical to develop strategies to prevent it. This comprises lifestyle changes to decrease bone loss and reduce the risk of falls, the identification and treatment of secondary causes of bone loss, and specific treatment for osteoporosis. Hormone replacement therapy, raloxifene, bisphosphonates, calcium and vitamin D, calcitonin, and parathyroid have all been displayed to enhance bone thickness and decrease the risk of fracture in specific situations.

Osteoporosis might be either primary (idiopathic) or secondary to one of the various identifiable causes. Regardless the outcome is a low BMD. There is a strong inverse connection between BMD and fracture risk, with an increase in fracture occurrence for every standard deviation decrease in BMD. Other factors affect the fracture risk of BMD, including bone turnover, trabecular architecture, and skeletal geometry [1-3]. The BMD at some stage is determined by the pinnacle bone mass accomplished, the resulting rate of loss, and the age at which that loss starts. One of the reasons for osteoporosis in women is the loss of sex steroids at menopause, which prompts increased bone turnover and bone loss. Sex steroids have a significant impact on the maintenance of bone density in men, as exhibited by the quick bone loss seen after castration.

Up to 25% of men with symptomatic vertebral fractures and 55% of men with hip cracks are hypogonadal. However, the BMD and the prevalence of vertebral fracture in men are connected with serum oestradiol, yet not to serum testosterone. Moreover, oestradiol appears to be the dominant sex hormone regulating bone resorption in men. In this model intrauterine turn of events, hereditary and natural elements communicate to decide the pinnacle bone mass. Declining sex steroid concentrations, which affect bone turnover, impact the subsequent rate of bone loss. The significant endpoint of osteoporosis is a fracture, particularly distal arm, vertebral, and hip. Formerly, the diagnosis was made based on a low trauma fracture, characterized as a fall from a standing height [4]. As there is an inverse connection between BMD and fracture risk strategies have been created to measure BMD. The most broadly used of these is double energy x-ray absorptiometry.

The World Health Organization (WHO) has characterized osteoporosis as a BMD 2.5 standard deviations or more under the mean value for young adults (T score <−2.5), while the term extreme or established osteoporosis shows that there have also been at least one fragility fractures. The WHO characterizes osteopenia as a BMD T score somewhere in the range of −1.0 and −2.5. Even though the WHO definition is helpful for the diagnosis of osteoporosis, it doesn't necessarily represent an edge for treatment. This is significant as 70% of women over the age of 80 years have a T score of under −2.5, yet just an extent of these will support an osteoporotic fracture [5]. BMD can be estimated at a number of sites, yet the total hip is normally accepted to be the most reliable for diagnostic purposes, as it predicts femoral neck and trochanteric fractures, and has the best precision.

References

Author Info

Manchala Agarwal*
 
Department of Sports and Physical Fitness, University of Hyderabad, Hyderabad, India
 

Citation: Agarwal M (2022) Pathogenesis and Diagnosis of Osteoporosis. J Osteopor Phys Act. 10:307.

Received: 12-May-2022, Manuscript No. JOPA-22-17892; Editor assigned: 16-May-2022, Pre QC No. JOPA-22-17892 (PQ); Reviewed: 30-May-2022, QC No. JOPA-22-17892; Revised: 06-Jun-2022, Manuscript No. JOPA-22-17892 (R); Published: 15-Jun-2022 , DOI: 10.35841/2329-9509.22.10.307

Copyright: © 2022 Agarwal M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top